Neovascularization — New Blood Vessel Formation & PDRN

Neovascularization refers to the formation of new blood vessels in tissues where they were previously absent or insufficient. While often used interchangeably with angiogenesis, neovascularization is a broader term that encompasses both angiogenesis (sprouting from existing vessels) and vasculogenesis (recruitment of circulating endothelial progenitor cells) . In dermatology and regenerative skincare, neovascularization is a fundamental process that determines how effectively damaged or aging skin can repair and rejuvenate itself.

Types of Neovascularization

Neovascularization occurs through three distinct mechanisms:

Angiogenesis

The most common form in adult tissue, angiogenesis involves the sprouting of new capillaries from pre-existing blood vessels. Endothelial cells in existing vessels respond to pro-angiogenic signals such as VEGF by degrading the basement membrane, migrating, proliferating, and forming new tubular structures .

Vasculogenesis

Originally thought to occur only during embryonic development, postnatal vasculogenesis involves the mobilization of bone marrow-derived endothelial progenitor cells (EPCs) that circulate in the blood and incorporate into sites of active neovascularization . This process contributes to vascular repair and new vessel formation in adults.

Arteriogenesis

The remodeling and enlargement of pre-existing collateral arterioles into functional arteries. This process is driven by increased shear stress and inflammatory signaling rather than by hypoxia-induced VEGF production.

The Role of VEGF in Neovascularization

Vascular endothelial growth factor (VEGF) is the master regulator of neovascularization. VEGF acts on endothelial cells by binding to VEGF receptor-2 (VEGFR-2), triggering a cascade of intracellular signals that promote :

Endothelial cell survival — Activation of anti-apoptotic pathways
Cell proliferation — Stimulation of mitogenic signaling
Migration — Chemotactic movement toward hypoxic tissue
Vascular permeability — Increased extravasation of plasma proteins that form a provisional matrix
Tube formation — Organization of endothelial cells into functional capillary structures

In skin, VEGF is produced by keratinocytes, fibroblasts, macrophages, and other cell types in response to hypoxia, growth factor signaling, and tissue injury.

Neovascularization in Wound Healing

Neovascularization is one of the most critical events during the proliferative phase of wound healing. Without new blood vessels, the regenerating tissue cannot receive the oxygen and nutrients necessary for collagen synthesis, extracellular matrix deposition, and cellular proliferation .

The process follows a coordinated timeline:

Inflammatory phase (days 1-3) — Damaged vessels release clotting factors; macrophages begin producing VEGF
Proliferative phase (days 3-21) — Robust neovascularization creates granulation tissue rich in new capillaries
Remodeling phase (weeks to months) — Excess vessels regress as the tissue matures; the vascular network stabilizes

Impaired neovascularization — as seen in diabetic wounds, chronic ulcers, and aged skin — results in delayed healing, persistent inflammation, and poor tissue quality.

PDRN and Neovascularization

PDRN (polydeoxyribonucleotide) is a potent stimulator of neovascularization, acting through multiple complementary pathways :

A2A Receptor-Mediated VEGF Upregulation

PDRN activates the adenosine A2A receptor on endothelial cells and surrounding tissue cells. This activation upregulates VEGF expression, creating a pro-angiogenic environment that drives endothelial cell proliferation, migration, and tube formation. Studies in diabetic wound models have demonstrated significantly increased VEGF levels and capillary density in PDRN-treated tissues .

Direct Endothelial Cell Stimulation

Beyond VEGF upregulation, A2A receptor activation on endothelial cells directly stimulates intracellular cAMP-PKA signaling, which promotes endothelial cell survival and proliferative capacity .

Anti-Inflammatory Modulation

Chronic inflammation produces disorganized, leaky vessels that are functionally inadequate. PDRN's anti-inflammatory properties — mediated through A2A receptor-dependent suppression of pro-inflammatory cytokines such as TNF-alpha and IL-6 — create conditions favorable for organized, functional neovascularization rather than pathological vessel formation.

Nucleotide Salvage Support

The nucleotide fragments released from PDRN metabolism enter rapidly dividing endothelial cells via the salvage pathway, supplying the purine and pyrimidine building blocks required for DNA replication during cell proliferation.

Clinical Relevance in Dermatology

Skin Rejuvenation

Age-related decline in dermal vascularity contributes to skin thinning, reduced nutrient delivery, and impaired cellular metabolism. PDRN-driven neovascularization helps restore the microvascular network that sustains dermal health and a youthful appearance.

Scar Remodeling

Mature scars are typically avascular, limiting their capacity for remodeling. By promoting neovascularization within scar tissue, PDRN creates the vascular infrastructure necessary for fibroblast activity and collagen turnover.

Post-Procedure Recovery

Following ablative procedures such as laser resurfacing or deep chemical peels, rapid neovascularization is essential to supply the healing dermis. PDRN's pro-neovascular effects support faster recovery and improved outcomes.

Angiogenesis — Sprouting of new vessels from existing vasculature, a subset of neovascularization
Wound Healing — The clinical process most dependent on neovascularization
Growth Factors — Signaling molecules including VEGF that regulate neovascularization
Adenosine A2A Receptor — The receptor through which PDRN promotes neovascularization
Tissue Regeneration — The broader regenerative process supported by new blood vessel formation